Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenografts.

BMC Cancer · 2013 · PMC3846908 · PMID 24024776

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

We show in Figure 2 that APMS-MB-DOX (0.05 mg/kg) significantly reduces tumor volume compared to untreated (saline) tumors, whereas free DOX at the same concentration did not achieve significance in reduction of tumor volume.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.